Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

Market Cap	12.17B +43.7%
Revenue (ttm)	674.49M -10.3%
Net Income	23.29M -82.7%
EPS	0.05 -83.0%
Shares Out	423.51M
PE Ratio	522.62
Forward PE	n/a
Dividend	0.20 (0.69%)
Ex-Dividend Date	May 27, 2025

Volume	4,432,675
Average Volume	4,663,594
Open	29.07
Previous Close	29.14
Day's Range	28.56 - 29.45
52-Week Range	19.30 - 42.26
Beta	0.34
RSI	52.37
Earnings Date	Apr 28, 2026

About SHE:301263

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 1,081
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301263

Financial Performance

In 2024, SHE:301263's revenue was 721.03 million, a decrease of -5.23% compared to the previous year's 760.79 million. Earnings were 108.22 million, a decrease of -32.45%.